ATE52030T1 - Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen. - Google Patents

Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen.

Info

Publication number
ATE52030T1
ATE52030T1 AT85100222T AT85100222T ATE52030T1 AT E52030 T1 ATE52030 T1 AT E52030T1 AT 85100222 T AT85100222 T AT 85100222T AT 85100222 T AT85100222 T AT 85100222T AT E52030 T1 ATE52030 T1 AT E52030T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
medications
liver injuries
liver
Prior art date
Application number
AT85100222T
Other languages
English (en)
Inventor
Gabriel L Garay
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE52030T1 publication Critical patent/ATE52030T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85100222T 1984-01-13 1985-01-11 Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen. ATE52030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57071284A 1984-01-13 1984-01-13
EP85100222A EP0149475B1 (de) 1984-01-13 1985-01-11 Arzneimittel für die Behandlung und Verhütung von Leberschädigungen

Publications (1)

Publication Number Publication Date
ATE52030T1 true ATE52030T1 (de) 1990-05-15

Family

ID=24280742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85100222T ATE52030T1 (de) 1984-01-13 1985-01-11 Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen.

Country Status (4)

Country Link
EP (1) EP0149475B1 (de)
JP (1) JPS60208914A (de)
AT (1) ATE52030T1 (de)
DE (1) DE3577184D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2011063C (en) * 1989-02-28 1999-07-06 Calum B. Macfarlane Nicardipine pharmaceutical composition for parenteral administration
WO1993002670A1 (en) * 1991-07-27 1993-02-18 Bayer Aktiengesellschaft Radioprotection by calcium antagonists
WO2007121483A2 (en) 2006-04-18 2007-10-25 Ekr Therapeutics, Inc. Pre-mixed, ready-to-use iv bolus compositions and methods of use
CN111955727B (zh) * 2020-08-21 2022-08-09 华熙生物科技股份有限公司 四氢嘧啶类物质的应用及含四氢嘧啶类物质的饮用酒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
FR2248028A1 (en) * 1973-10-18 1975-05-16 Ordena Trudovogo Krasnogo Znamen,Su 2,6-Dimethyl-3,5-dicarbonyl (or dicyano)-1,4-dihydropyridine prepns - used in treatment of hepatic diseases caused by peroxidative damage of biological membranes
JPS58159490A (ja) * 1982-02-23 1983-09-21 Nikken Kagaku Kk 1,4−ジヒドロピリジン化合物
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
EP0149475A3 (en) 1985-09-18
EP0149475A2 (de) 1985-07-24
DE3577184D1 (de) 1990-05-23
EP0149475B1 (de) 1990-04-18
JPS60208914A (ja) 1985-10-21

Similar Documents

Publication Publication Date Title
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
PT1040830E (pt) Medicamento para doencas neurodegenerativas
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
NO871549D0 (no) Medikament for behandling av oeyenbetennelser.
DE59310399D1 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
DE3686483D1 (de) Arzneimittel.
ATE2667T1 (de) Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus.
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
PT83872A (de) Arzneimittel
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
FI853649A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler.
ES2088959T3 (es) 11-beta-aril-4-estreno, procedimiento para su preparacion y aplicacion como medicamento.
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DE3577184D1 (de) Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen.
NO891024L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktivekinolin- og acridinforbindelser.
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
EP0261524A3 (de) Arzneimittelzubereitungen
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee